AVIDITY BIOSCIENCES INC's ticker is RNA and the CUSIP is 05370A108. A total of 115 filers reported holding AVIDITY BIOSCIENCES INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $6,619,293 | +131.8% | 162,039 | +44.8% | 0.00% | +100.0% |
| Q1 2024 | $2,856,045 | +349.2% | 111,914 | +59.3% | 0.00% | – |
| Q4 2023 | $635,808 | -41.6% | 70,255 | -58.8% | 0.00% | – |
| Q3 2023 | $1,088,760 | -39.5% | 170,652 | +5.2% | 0.00% | -100.0% |
| Q2 2023 | $1,799,463 | +73.7% | 162,260 | +140.4% | 0.00% | – |
| Q1 2023 | $1,035,925 | +173.2% | 67,487 | +294.9% | 0.00% | – |
| Q4 2022 | $379,227 | -43.1% | 17,090 | -62.7% | 0.00% | – |
| Q2 2022 | $666,000 | +144.0% | 45,821 | +313.4% | 0.00% | – |
| Q3 2021 | $273,000 | -31.9% | 11,085 | -21.8% | 0.00% | – |
| Q2 2020 | $401,000 | – | 14,182 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ALETHEA CAPITAL MANAGEMENT, LLC | 503,504 | $20,568,138 | 15.61% |
| Casdin Capital, LLC | 2,084,841 | $85,165,755 | 6.53% |
| COWEN AND COMPANY, LLC | 5,129,103 | $209,523,857 | 5.76% |
| RTW INVESTMENTS, LP | 8,806,838 | $359,759,332 | 5.57% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 517,734 | $21,149,434 | 4.99% |
| Propel Bio Management, LLC | 178,500 | $7,291,725 | 4.73% |
| Boxer Capital, LLC | 1,727,388 | $70,563,800 | 3.72% |
| Avoro Capital Advisors LLC | 6,505,000 | $265,729,250 | 3.54% |
| RA Capital Management | 5,400,408 | $220,606,667 | 2.92% |
| EAM Global Investors LLC | 116,615 | $4,763,723 | 1.07% |